General form of registration statement for all companies including face-amount certificate companies

Consolidated Statements of Changes in Stockholders' Deficit (Unaudited)

v3.23.3
Consolidated Statements of Changes in Stockholders' Deficit (Unaudited) - USD ($)
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Total
Balance at September 30, 2021 (in shares) at Sep. 30, 2020 965,224      
Balance at September 30, 2021 at Sep. 30, 2020 $ 965 $ 42,054,981 $ (43,556,437) $ (1,500,491)
Net loss $ 0 0 (6,240,482) (6,240,482)
Stock-based compensation expense   496,066 0 496,066
Issuance of common stock and warrants, net of financing costs (in shares) 215,625      
Issuance of common stock and warrants, net of financing costs $ 216 6,219,017 0 6,219,233
Balance at September 30, 2021 (in shares) at Sep. 30, 2021 1,183,599      
Balance at September 30, 2021 at Sep. 30, 2021 $ 1,184 48,770,061 (49,796,919) (1,025,674)
Net loss 0 0 (3,387,295) (3,387,295)
Stock-based compensation expense $ 0 397,470 0 397,470
Balance at September 30, 2021 (in shares) at Sep. 30, 2021 1,183,599      
Balance at September 30, 2021 at Sep. 30, 2021 $ 1,184 48,770,061 (49,796,919) (1,025,674)
Net loss $ 0 0 (5,275,854) (5,275,854)
Stock-based compensation expense   499,584 0 499,584
Issuance of common stock and warrants, net of financing costs (in shares) 63,833      
Issuance of common stock and warrants, net of financing costs $ 64 1,609,077 0 1,609,141
Balance at September 30, 2021 (in shares) at Mar. 31, 2022 1,184,599      
Balance at September 30, 2021 at Mar. 31, 2022 $ 1,185 49,076,775 (52,137,384) (3,059,424)
Net loss     (1,046,830) (1,046,830)
Stock-based compensation expense   90,755   90,755
Balance at September 30, 2021 (in shares) at Sep. 30, 2022 1,249,432      
Balance at September 30, 2021 at Sep. 30, 2022 $ 1,249 50,878,721 (55,072,773) (4,192,803)
Net loss 0 0 (4,525,640) (4,525,640)
Stock-based compensation expense $ 0 213,809 0 213,809
Issuance of common stock and warrants, net of financing costs (in shares) 20,210      
Issuance of common stock and warrants, net of financing costs $ 20 440,308 0 $ 440,328
Exchange of warrants into common stock (in shares) 12,019     0
Exchange of warrants into common stock $ 13 49,265   $ 49,278
Balance at September 30, 2021 at Dec. 31, 2022       (4,192,803)
Net loss       (4,525,640)
Balance at September 30, 2021 (in shares) at Mar. 31, 2023 1,274,605      
Balance at September 30, 2021 at Mar. 31, 2023 $ 1,275 51,387,943 (57,775,306) (6,386,088)
Net loss     (1,823,107) (1,823,107)
Stock-based compensation expense   41,259 0 41,259
Issuance of common stock and warrants, net of financing costs (in shares) 10,608      
Issuance of common stock and warrants, net of financing costs $ 10 152,898 0 152,908
Exchange of warrants into common stock (in shares) 0      
Exchange of warrants into common stock $ 0 $ 0 $ 0 $ 0